Articles:

Proceedings of the International Symposium on Aromatase and its Inhibition: New Biology and Clinical Perspectives. Prague, Czech Republic. 3-6 September 1998

Endocr Relat Cancer 1999 6: 127-333.  

WR Miller

Aromatase and its inhibitors: new biology and clinical perspectives

Endocr Relat Cancer 1999 6: 127-130. [PDF]  

E Simpson, G Rubin, C Clyne, K Robertson, L O'Donnell, S Davis, and M Jones

Local estrogen biosynthesis in males and females

Endocr Relat Cancer 1999 6: 131-137. [Abstract] [PDF]  

A Singh, A Purohit, MW Ghilchik, and MJ Reed

The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2

Endocr Relat Cancer 1999 6: 139-147. [Abstract] [PDF]  

S Chen, D Zhou, T Okubo, YC Kao, and C Yang

Breast tumor aromatase: functional role and transcriptional regulation

Endocr Relat Cancer 1999 6: 149-156. [Abstract] [PDF]  

W Yue, RJ Santen, JP Wang, CJ Hamilton, and LM Demers

Aromatase within the breast

Endocr Relat Cancer 1999 6: 157-164. [Abstract] [PDF]  

NM Probst-Hensch, SA Ingles, AT Diep, RW Haile, FZ Stanczyk, LN Kolonel, and BE Henderson

Aromatase and breast cancer susceptibility

Endocr Relat Cancer 1999 6: 165-173. [Abstract] [PDF]  

TJ Key

Serum oestradiol and breast cancer risk

Endocr Relat Cancer 1999 6: 175-180. [Abstract] [PDF]  

M Dowsett

Drug and hormone interactions of aromatase inhibitors

Endocr Relat Cancer 1999 6: 181-185. [Abstract] [PDF]  

WR Miller

Biology of aromatase inhibitors: pharmacology/endocrinology within the breast

Endocr Relat Cancer 1999 6: 187-195. [Abstract] [PDF]  

H Sasano, S Sato, K Ito, A Yajima, J Nakamura, M Yoshihama, K Ariga, TJ Anderson, and WR Miller

Effects of aromatase inhibitors on the pathobiology of the human breast, endometrial and ovarian carcinoma

Endocr Relat Cancer 1999 6: 197-204. [Abstract] [PDF]  

A Brodie, Q Lu, Y Liu, and B Long

Aromatase inhibitors and their antitumor effects in model systems

Endocr Relat Cancer 1999 6: 205-210. [Abstract] [PDF]  

N Harada, SI Honda, and O Hatano

Aromatase inhibitors and enzyme stability

Endocr Relat Cancer 1999 6: 211-218. [Abstract] [PDF]  

AU Buzdar

Role of aromatase inhibitors in advanced breast cancer

Endocr Relat Cancer 1999 6: 219-225. [Abstract] [PDF]  

JM Dixon, CD Love, L Renshaw, C Bellamy, DA Cameron, WR Miller, and RC Leonard

Lessons from the use of aromatase inhibitors in the neoadjuvant setting

Endocr Relat Cancer 1999 6: 227-230. [Abstract] [PDF]  

M Baum

Use of aromatase inhibitors in the adjuvant treatment of breast cancer

Endocr Relat Cancer 1999 6: 231-234. [Abstract] [PDF]  

RJ Santen, W Yue, F Naftolin, G Mor, and L Berstein

The potential of aromatase inhibitors in breast cancer prevention

Endocr Relat Cancer 1999 6: 235-243. [Abstract] [PDF]  

IE Smith

Aromatase inhibitors: a dose-response effect?

Endocr Relat Cancer 1999 6: 245-249. [PDF]  

PE Lonning

Cross-resistance to different aromatase inhibitors in breast cancer treatment

Endocr Relat Cancer 1999 6: 251-257. [Abstract] [PDF]  

RC Coombes, C Harper-Wynne, and M Dowsett

Aromatase inhibitors and their use in the sequential setting

Endocr Relat Cancer 1999 6: 259-263. [Abstract] [PDF]  

JN Ingle, VJ Suman, VC Jordan, and M Dowsett

Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer

Endocr Relat Cancer 1999 6: 265-269. [Abstract] [PDF]  

CK Osborne

Aromatase inhibitors in relation to other forms of endocrine therapy for breast cancer

Endocr Relat Cancer 1999 6: 271-276. [Abstract] [PDF]  

J Ragaz

Status of aromatase inhibitors in relation to other breast cancer treatment modalities

Endocr Relat Cancer 1999 6: 277-291. [Abstract] [PDF]  

SE Bulun, K Zeitoun, K Takayama, L Noble, D Michael, E Simpson, A Johns, M Putman, and H Sasano

Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis

Endocr Relat Cancer 1999 6: 293-301. [Abstract] [PDF]  

P Feuillan, D Merke, EW Leschek, and Cutler GB, Jr

Use of aromatase inhibitors in precocious puberty

Endocr Relat Cancer 1999 6: 303-306. [Abstract] [PDF]  

RR Tekmal, N Kirma, K Gill, and K Fowler

Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands

Endocr Relat Cancer 1999 6: 307-314. [Abstract] [PDF]  

GD Braunstein

Aromatase and gynecomastia

Endocr Relat Cancer 1999 6: 315-324. [Abstract] [PDF]  

PE Goss

Risks versus benefits in the clinical application of aromatase inhibitors

Endocr Relat Cancer 1999 6: 325-332. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.